1. Preparation and Characterization of α-<scp>d</scp>-Glucopyranosyl-α-acarviosinyl-<scp>d</scp>-glucopyranose, a Novel Inhibitor Specific for Maltose-Producing Amylase
- Author
-
Heeseob Lee, Jung-Wan Kim, Tae-Jip Kim, Myo-Jeong Kim, Kwan-Hwa Park, Tae-Wha Moon, Byung-Ha Oh, Sang-Taek Oh, and Jin-Sook Cho
- Subjects
Conformational change ,Stereochemistry ,Dimer ,Molecular Sequence Data ,Oligosaccharides ,Biochemistry ,Hydrolysis ,chemistry.chemical_compound ,medicine ,Amylase ,Enzyme Inhibitors ,Maltose ,Chromatography, High Pressure Liquid ,Acarbose ,chemistry.chemical_classification ,biology ,Chemistry ,Thermus ,biology.organism_classification ,Enzyme ,Carbohydrate Sequence ,Amylases ,biology.protein ,Chromatography, Thin Layer ,medicine.drug - Abstract
A novel inhibitor against maltose-producing alpha-amylase was prepared via stepwise degradation of a high-molecular-weight acarbose (HMWA) using Thermus maltogenic amylase (ThMA). The structure of the purified inhibitor was determined to be alpha-D-glucopyranosyl-alpha-acarviosinyl-D-glucopyranose (GlcAcvGlc) by (13)C NMR and MALDI-TOF/MS. Progress curves of PNPG2 hydrolysis by various amylolytic enzymes, including MGase, ThMA, and CDase I-5, in the presence of acarbose or GlcAcvGlc indicated a slow-binding mode of inhibition. Analytical ultracentrifugation and X-ray crystallography analyses revealed that the presence of GlcAcvGlc increased the dimerization of ThMA. The formation of dimer complexed with GlcAcvGlc might induce a conformational change in ThMA, leading to a two-step inhibition process. The inhibition potency of GlcAcvGlc for MGase, ThMA, and CDase I-5 was 3 orders of magnitude higher than that of acarbose.
- Published
- 2002
- Full Text
- View/download PDF